Correlation Between Valneva SE and Agios Pharm

Can any of the company-specific risk be diversified away by investing in both Valneva SE and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Valneva SE ADR and Agios Pharm, you can compare the effects of market volatilities on Valneva SE and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Agios Pharm.

Diversification Opportunities for Valneva SE and Agios Pharm

-0.43

Correlation Coefficient

Valneva SE  Agios Pharm

Very good diversification

The 3 months correlation between Valneva and Agios is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Valneva SE i.e., Valneva SE and Agios Pharm go up and down completely randomly.

Pair Corralation between Valneva SE and Agios Pharm

Given the investment horizon of 90 days Valneva SE ADR is expected to generate 1.34 times more return on investment than Agios Pharm. However, Valneva SE is 1.34 times more volatile than Agios Pharm. It trades about 0.2 of its potential returns per unit of risk. Agios Pharm is currently generating about -0.19 per unit of risk. If you would invest  405.00  in Valneva SE ADR on November 29, 2024 and sell it today you would earn a total of  331.00  from holding Valneva SE ADR or generate 81.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Valneva SE ADR  vs.  Agios Pharm

Valneva SE ADR

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Valneva SE ADR are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain essential indicators, Valneva SE displayed solid returns over the last few months and may actually be approaching a breakup point.

Agios Pharm

Risk-Adjusted Performance

Very Weak

Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Valneva SE and Agios Pharm

The main advantage of trading using opposite Valneva SE and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.

The idea behind Valneva SE ADR and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.